Can-Fite BioPharma Ltd. (CANF)
1.90
-0.10
(-5.00%)
USD |
NYAM |
Oct 09, 16:00
1.91
+0.01
(+0.53%)
After-Hours: 20:00
Can-Fite BioPharma Price to Book Value : 1.380 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.380 |
| October 08, 2026 | 1.452 |
| October 07, 2026 | 1.525 |
| October 06, 2026 | 1.554 |
| October 05, 2026 | 1.554 |
| October 02, 2026 | 1.584 |
| October 01, 2026 | 1.605 |
| September 30, 2026 | 1.597 |
| September 29, 2026 | 1.583 |
| September 28, 2026 | 1.619 |
| September 25, 2026 | 1.570 |
| September 24, 2026 | 1.576 |
| September 23, 2026 | 1.568 |
| September 22, 2026 | 1.619 |
| September 21, 2026 | 1.612 |
| September 18, 2026 | 1.626 |
| September 17, 2026 | 1.626 |
| September 16, 2026 | 1.626 |
| September 15, 2026 | 1.626 |
| September 14, 2026 | 1.670 |
| September 11, 2026 | 1.692 |
| September 10, 2026 | 1.568 |
| September 09, 2026 | 1.590 |
| September 08, 2026 | 1.663 |
| September 04, 2026 | 1.619 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.706 |
| September 02, 2026 | 1.714 |
| September 01, 2026 | 2.389 |
| August 31, 2026 | 2.309 |
| August 28, 2026 | 2.469 |
| August 27, 2026 | 2.447 |
| August 26, 2026 | 2.410 |
| August 25, 2026 | 2.410 |
| August 24, 2026 | 2.432 |
| August 21, 2026 | 2.418 |
| August 20, 2026 | 2.432 |
| August 19, 2026 | 2.527 |
| August 18, 2026 | 2.505 |
| August 17, 2026 | 2.599 |
| August 14, 2026 | 2.469 |
| August 13, 2026 | 2.469 |
| August 12, 2026 | 2.498 |
| August 11, 2026 | 2.403 |
| August 10, 2026 | 2.331 |
| August 07, 2026 | 2.498 |
| August 06, 2026 | 2.585 |
| August 05, 2026 | 2.323 |
| August 04, 2026 | 2.316 |
| August 03, 2026 | 2.302 |
| July 31, 2026 | 2.287 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.703 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.729 |
| Eocene Ltd. | 0.2783 |
| Revium Recovery, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 7.379 |
| Price | 1.90 |
| Earnings Yield | -331.5% |
| Market Cap | 4.071M |